Patent · US Active

Bendamustine derivatives and related compounds, and medical use thereof in cancer therapy

US10526290B2 · kind B2 · utility

0Cited by

1References

7Claims

0Family size

Assignee

SYNBIAS PHARMA AG · CH

Inventors

Helmut Schickaneder · Eckental, DE
Christian Schickaneder · Achern, DE
Armin Buschauer · Berlin, DE
Stefan Huber · Regensburg, DE
Michael Limmert · Dresden, DE
Gunther Bernhardt · Sankt Augustin, DE
Mathias Lubbe · Dresden, DE
Harald Hofmeier · Dresden, DE

Key dates

Filing date	Jun 14, 2013
Grant date	Jan 7, 2020
Priority date	—
Expiry date	Jun 14, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C231/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to bendamustine derivatives and related compounds of formula (VII), (VIII) and (IX), and medical uses thereof in particular in cancer therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.